Search by Drug Name or NDC

    NDC 69489-0121-03 Ximino 45 mg/1 Details

    Ximino 45 mg/1

    Ximino is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Journey Medical Corporation. The primary component is MINOCYCLINE HYDROCHLORIDE.

    Product Information

    NDC 69489-0121
    Product ID 69489-121_a963e02a-adbc-49f1-9e74-c1722f92902d
    Associated GPIs 04000040107010
    GCN Sequence Number 077813
    GCN Sequence Number Description minocycline HCl CAP ER 24H 45 MG ORAL
    HIC3 W1C
    HIC3 Description TETRACYCLINE ANTIBIOTICS
    GCN 43962
    HICL Sequence Number 004015
    HICL Sequence Number Description MINOCYCLINE HCL
    Brand/Generic Brand
    Proprietary Name Ximino
    Proprietary Name Suffix n/a
    Non-Proprietary Name minocycline hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 45
    Active Ingredient Units mg/1
    Substance Name MINOCYCLINE HYDROCHLORIDE
    Labeler Name Journey Medical Corporation
    Pharmaceutical Class Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA201922
    Listing Certified Through n/a

    Package

    NDC 69489-0121-03 (69489012103)

    NDC Package Code 69489-121-03
    Billing NDC 69489012103
    Package 3 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (69489-121-03)
    Marketing Start Date 2020-11-08
    NDC Exclude Flag N
    Pricing Information N/A